Clinical Trial Update: Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating intravitreal infliximab for refractory uveitis in Behçet's disease, assessing safety and efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Uveitis

Drugs mentioned

• Infliximab (intravitreal) (infliximab)

Snippet

Sponsor: Cairo University | Conditions: Behçet's Disease, Uveitis | Phase 1, Phase 2 | Status: COMPLETED